These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 34227872)
1. Cannabis Exposure Decreases Need for Blood Pressure Support During General Anesthesia in Orthopedic Trauma Surgery. Yeung BG; Ma MW; Scolaro JA; Nelson AM Cannabis Cannabinoid Res; 2022 Jun; 7(3):328-335. PubMed ID: 34227872 [No Abstract] [Full Text] [Related]
2. Evaluation of pre-hospital cannabis exposure and hospital opioid utilization in a trauma population: A retrospective cohort. Chang AJ; Mallat AF; Edwards MJ; Gabra JN; Cucci MD Injury; 2024 May; 55(5):111305. PubMed ID: 38216357 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Marijuana on Postoperative Spine Patients' Emergency Department Visits, Readmission Rates, and Opioid Consumption. Buddle VP; Lee M; Feng J; Khurana E; Park A; Park D J Am Acad Orthop Surg Glob Res Rev; 2024 Feb; 8(2):. PubMed ID: 38323931 [TBL] [Abstract][Full Text] [Related]
4. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. Bidwell LC; Karoly HC; Torres MO; Master A; Bryan AD; Hutchison KE Psychopharmacology (Berl); 2022 Feb; 239(2):385-397. PubMed ID: 34708254 [TBL] [Abstract][Full Text] [Related]
5. 'Synthetic cannabis': A dangerous misnomer. Darke S; Banister S; Farrell M; Duflou J; Lappin J Int J Drug Policy; 2021 Dec; 98():103396. PubMed ID: 34343944 [TBL] [Abstract][Full Text] [Related]
6. Investigating the "two-hit hypothesis": Effects of prenatal maternal immune activation and adolescent cannabis use on neurodevelopment in mice. Guma E; Cupo L; Ma W; Gallino D; Moquin L; Gratton A; Devenyi GA; Chakravarty MM Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110642. PubMed ID: 36150422 [TBL] [Abstract][Full Text] [Related]
7. Can cannabis kill? Characteristics of deaths following cannabis use in England (1998-2020). Rock KL; Englund A; Morley S; Rice K; Copeland CS J Psychopharmacol; 2022 Dec; 36(12):1362-1370. PubMed ID: 35946604 [TBL] [Abstract][Full Text] [Related]
9. Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney Dysfunction. Bonnet U; Borda T; Scherbaum N; Specka M Cannabis Cannabinoid Res; 2022 Oct; 7(5):670-676. PubMed ID: 34704814 [No Abstract] [Full Text] [Related]
10. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389 [TBL] [Abstract][Full Text] [Related]
11. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC. Kruger DJ; Kruger JS Cannabis Cannabinoid Res; 2023 Feb; 8(1):166-173. PubMed ID: 34797727 [No Abstract] [Full Text] [Related]
12. Impact of marijuana legalization on cannabis-related visits to the emergency department. Tolan NV; Terebo T; Chai PR; Erickson TB; Hayes BD; Uljon SN; Petrides AK; Demetriou CA; Melanson SEF Clin Toxicol (Phila); 2022 May; 60(5):585-595. PubMed ID: 34935567 [TBL] [Abstract][Full Text] [Related]
13. Enhanced cannabis timeline followback (EC-TLFB): Comprehensive assessment of cannabis use including standard THC units and validation through biological measures. Petrilli K; Lawn W; Lees R; Mokrysz C; Borissova A; Ofori S; Trinci K; Dos Santos R; Leitch H; Soni S; Hines LA; Lorenzetti V; Curran HV; Freeman TP Addiction; 2024 Apr; 119(4):772-783. PubMed ID: 38105033 [TBL] [Abstract][Full Text] [Related]
14. The Relationship Between Circulating Endogenous Cannabinoids and the Effects of Smoked Cannabis. Kearney-Ramos T; Herrmann ES; Belluomo I; Matias I; Vallée M; Monlezun S; Piazza PV; Haney M Cannabis Cannabinoid Res; 2023 Dec; 8(6):1069-1078. PubMed ID: 35486827 [No Abstract] [Full Text] [Related]
15. Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases. Thapa D; Warne LN; Falasca M Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834122 [TBL] [Abstract][Full Text] [Related]
16. Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services. Oomen PE; Schori D; Tögel-Lins K; Acreman D; Chenorhokian S; Luf A; Karden A; Paulos C; Fornero E; Gerace E; Koning RPJ; Galindo L; Smit-Rigter LA; Measham F; Ventura M Int J Drug Policy; 2022 Feb; 100():103493. PubMed ID: 34687992 [TBL] [Abstract][Full Text] [Related]
17. Cannabis and cannabinoids: pharmacology and rationale for clinical use. Pertwee RG Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283 [TBL] [Abstract][Full Text] [Related]
19. Cannabis and Paternal Epigenetic Inheritance. Mazzeo F; Meccariello R Int J Environ Res Public Health; 2023 Apr; 20(9):. PubMed ID: 37174181 [TBL] [Abstract][Full Text] [Related]
20. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]